Degradation of tau protein by autophagy and proteasomal pathways

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 644-652

  Wang, Yipeng ^a   Mandelkow, Eckhard ^a,b,c  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^c DESY   (Germany)

Author keywords

Aggregation; Autophagy; Proteasome; Tau; Ubiquitination

Indexed keywords

PROTEASOME; PROTEINASE; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; AUTOPHAGY; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE SEVERITY; HUMAN; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; TAUOPATHY;

ANIMALS; AUTOPHAGY; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84864389698     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120071     Document Type: Conference Paper

References (100)

1. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. 8, 663-672 (Pubitemid 47283144)
2. Schneider, A. and Mandelkow, E. (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5, 443-457 (Pubitemid 351952490)
3. Goedert, M., Ghetti, B. and Spillantini, M.G. (2012) Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harbor Perspect. Med. 2, a006254
4. Wang, Y., Garg, S., Mandelkow, E.M. and Mandelkow, E. (2010) Proteolytic processing of tau. Biochem. Soc. Trans. 38, 955-961
5. Park, S.Y. and Ferreira, A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration. J. Neurosci. 25, 5365-5375
6. Nicholson, A.M. and Ferreira, A. (2009) Increased membrane cholesterol might render mature hippocampal neurons more susceptible to β-amyloid- induced calpain activation and tau toxicity. J. Neurosci. 29, 4640-4651
7. Ferreira, A. and Bigio, E.H. (2011) Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol. Med. 17, 676-685
8. Garg, S., Timm, T., Mandelkow, E.M., Mandelkow, E. and Wang, Y. (2011) Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment. Neurobiol. Aging 32, 1-14
9. Karsten, S.L., Sang, T.K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S. et al. (2006) A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 51, 549-560 (Pubitemid 44314079)
10. Sengupta, S., Horowitz, P.M., Karsten, S.L., Jackson, G.R., Geschwind, D.H., Fu, Y., Berry, R.W. and Binder, L.I. (2006) Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry 45, 15111-15119 (Pubitemid 44937024)
11. Chow, K.M., Guan, H. and Hersh, L.B. (2010) Aminopeptidases do not directly degrade tau protein. Mol. Neurodegener. 5, 48
12. Kudo, L.C., Parfenova, L., Ren, G., Vi, N., Hui, M., Ma, Z., Lau, K., Gray, M., Bardag-Gorce, F., Wiedau-Pazos, M. et al. (2011) Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice. Hum. Mol. Genet. 20, 1820-1833
13. Menzies, F.M., Hourez, R., Imarisio, S., Raspe, M., Sadiq, O., Chandraratna, D., O'Kane, C., Rock, K.L., Reits, E., Goldberg, A.L. and Rubinsztein, D.C. (2010) Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Hum. Mol. Genet. 19, 4573-4586
14. Wong, E. and Cuervo, A.M. (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harbor Perspect. Biol. 2, a006734
15. Shang, F. and Taylor, A. (2011) Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radical Biol. Med. 51, 5-16
16. Jariel-Encontre, I., Bossis, G. and Piechaczyk, M. (2008) Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 1786, 153-177
17. Mori, H., Kondo, J. and Ihara, Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644 (Pubitemid 17050146)
18. Perry, G., Friedman, R., Shaw, G. and Chau, V. (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. U.S.A. 84, 3033-3036 (Pubitemid 17064772)
19. Shaw, G. and Chau, V. (1988) Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain. Proc. Natl. Acad. Sci. U.S.A. 85, 2854-2858
20. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K. and Ihara, Y. (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160 (Pubitemid 23194405)
21. Cripps, D., Thomas, S.N., Jeng, Y., Yang, F., Davies, P. and Yang, A.J. (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J. Biol. Chem. 281, 10825-10838 (Pubitemid 43855505)
22. Tan, J.M., Wong, E.S., Kirkpatrick, D.S., Pletnikova, O., Ko, H.S., Tay, S.P., Ho, M.W., Troncoso, J., Gygi, S.P., Lee, M.K. et al. (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17, 431-439
23. Babu, J.R., Geetha, T. and Wooten, M.W. (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem. 94, 192-203 (Pubitemid 40911405)
24. Matenia, D. and Mandelkow, E.M. (2009) The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem. Sci. 34, 332-342
25. Cohen, T.J., Guo, J.L., Hurtado, D.E., Kwong, L.K., Mills, I.P., Trojanowski, J.Q. and Lee, V.M. (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2, 252
26. Hatakeyama, S., Matsumoto, M., Kamura, T., Murayama, M., Chui, D.H., Planel, E., Takahashi, R., Nakayama, K.I. and Takashima, A. (2004) U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy. J. Neurochem. 91, 299-307 (Pubitemid 39363429)
27. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714 (Pubitemid 38455958)
28. Shimura, H., Schwartz, D., Gygi, S.P. and Kosik, K.S. (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869-4876 (Pubitemid 38199082)
29. Grune, T., Botzen, D., Engels, M., Voss, P., Kaiser, B., Jung, T., Grimm, S., Ermak, G. and Davies, K.J. (2010) Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch. Biochem. Biophys. 500, 181-188
30. Dickey, C.A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R.M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C.B. et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117, 648-658 (Pubitemid 46348523)
31. Pickart, C.M. (2001) Ubiquitin enters the new millennium. Mol. Cell 8, 499-504
32. Thrower, J.S., Hoffman, L., Rechsteiner, M. and Pickart, C.M. (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (Pubitemid 30009229)
33. Iwatsubo, T., Hasegawa, M., Esaki, Y. and Ihara, Y. (1992) Lack of ubiquitin immunoreactivities at both ends of neuropil threads: possible bidirectional growth of neuropil threads. Am. J. Pathol. 140, 277-282
34. Thomas, S.N., Funk, K.E., Wan, Y., Liao, Z., Davies, P., Kuret, J. and Yang, A.J. (2012) Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach. Acta Neuropathol. 123, 105-117
35. Dickey, C.A., Yue, M., Lin, W.L., Dickson, D.W., Dunmore, J.H., Lee, W.C., Zehr, C., West, G., Cao, S., Clark, A.M. et al. (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci. 26, 6985-6996 (Pubitemid 44309866)
36. Sahara, N., Murayama, M., Mizoroki, T., Urushitani, M., Imai, Y., Takahashi, R., Murata, S., Tanaka, K. and Takashima, A. (2005) In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 94, 1254-1263 (Pubitemid 41232581)
37. David, D.C., Layfield, R., Serpell, L., Narain, Y., Goedert, M. and Spillantini, M.G. (2002) Proteasomal degradation of tau protein. J. Neurochem. 83, 176-185
38. Poppek, D., Keck, S., Ermak, G., Jung, T., Stolzing, A., Ullrich, O., Davies, K.J. and Grune, T. (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem. J. 400, 511-520 (Pubitemid 44974463)
39. 2+ -dependent proteasome protease system. J. Neural Transm. 112, 547-555
40. Wang, Y., Martinez-Vicente, M., Kruger, U., Kaushik, S., Wong, E., Mandelkow, E.M., Cuervo, A.M. and Mandelkow, E. (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 18, 4153-4170
41. Brown, M.R., Bondada, V., Keller, J.N., Thorpe, J. and Geddes, J.W. (2005) Proteasome or calpain inhibition does not alter cellular tau levels in neuroblastoma cells or primary neurons. J. Alzheimer's Dis. 7, 15-24 (Pubitemid 40387181)
42. Feuillette, S., Blard, O., Lecourtois, M., Frebourg, T., Campion, D. and Dumanchin, C. (2005) Tau is not normally degraded by the proteasome. J. Neurosci. Res. 80, 400-405 (Pubitemid 40780828)
43. Delobel, P., Leroy, O., Hamdane, M., Sambo, A.V., Delacourte, A. and Buee, L. (2005) Proteasome inhibition and Tau proteolysis: an unexpected regulation. FEBS Lett. 579, 1-5 (Pubitemid 40023365)
44. Kruger, U., Wang, Y., Kumar, S. and Mandelkow, E.M. (2011) Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2011.11.009
45. Rubinsztein, D.C. and Nixon, R.A. (2010) Rapamycin induces autophagic flux in neurons. Proc. Natl. Acad. Sci. U.S.A. 107, E181
46. Rose, C., Menzies, F.M., Renna, M., Acevedo-Arozena, A., Corrochano, S., Sadiq, O., Brown, S.D. and Rubinsztein, D.C. (2010) Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum. Mol. Genet. 19, 2144-2153
47. Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H. and Nixon, R.A. (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28, 6926-6937
48. Tsvetkov, A.S., Miller, J., Arrasate, M., Wong, J.S., Pleiss, M.A. and Finkbeiner, S. (2010) A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc. Natl. Acad. Sci. U.S.A. 107, 16982-16987
49. Dolan, P.J. and Johnson, G.V. (2010) A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J. Biol. Chem. 285, 21978-21987
50. Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N., Greengard, P. and Chiosis, G. (2007) Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc. Natl. Acad. Sci. U.S.A. 104, 9511-9516 (Pubitemid 47185810)
51. Zhang, Y.J., Xu, Y.F., Liu, Y.H., Yin, J., Li, H.L., Wang, Q. and Wang, J.Z. (2006) Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J. 20, 1431-1442 (Pubitemid 44943851)
52. Min, S.W., Cho, S.H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W.W., Huang, E.J., Shen, Y., Masliah, E., Mukherjee, C. et al. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966
53. Rubinsztein, D.C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780-786
54. Keck, S., Nitsch, R., Grune, T. and Ullrich, O. (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85, 115-122 (Pubitemid 36389701)
55. Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H. and LaFerla, F.M. (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332 (Pubitemid 39061125)
56. Hartl, F.U., Bracher, A. and Hayer-Hartl, M. (2011) Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332
57. Dou, F., Netzer, W.J., Tanemura, K., Li, F., Hartl, F.U., Takashima, A., Gouras, G.K., Greengard, P. and Xu, H. (2003) Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U.S.A. 100, 721-726 (Pubitemid 36126119)
58. Elliott, E., Tsvetkov, P. and Ginzburg, I. (2007) BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein. J. Biol. Chem. 282, 37276-37284
59. Carrettiero, D.C., Hernandez, I., Neveu, P., Papagiannakopoulos, T. and Kosik, K.S. (2009) The cochaperone BAG2 sweeps paired helical filament-insoluble tau from the microtubule. J. Neurosci. 29, 2151-2161
60. Yang, X., Chernenko, G., Hao, Y., Ding, Z., Pater, M.M., Pater, A. and Tang, S.C. (1998) Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 17, 981-989 (Pubitemid 28425408)
61. Elliott, E., Laufer, O. and Ginzburg, I (2009) BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins. J. Neurochem. 109, 1168-1178
62. Luders, J., Demand, J., Papp, O. and Hohfeld, J. (2000) Distinct isoforms of the cofactor BAG-1 differentially affect Hsc70 chaperone function. J. Biol. Chem. 275, 14817-14823 (Pubitemid 30337193)
63. Jinwal, U.K., Miyata, Y., Koren, III, J., Jones, J.R., Trotter, J.H., Chang, L., O'Leary, J., Morgan, D., Lee, D.C., Shults, C.L. et al. (2009) Chemical manipulation of hsp70 ATPase activity regulates tau stability. J. Neurosci. 29, 12079-12088
64. Wischik, C.M., Edwards, P.C., Lai, R.Y., Roth, M. and Harrington, C.R. (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. U.S.A. 93, 11213-11218 (Pubitemid 26333144)
65. Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M. and Hasegawa, M. (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem. 280, 7614-7623 (Pubitemid 40349654)
66. Schirmer, R.H., Adler, H., Pickhardt, M. and Mandelkow, E. (2011) 'Lest we forget you - methylene blue . . . '. Neurobiol. Aging 32, 2325-2327
67. Wang, A.M., Morishima, Y., Clapp, K.M., Peng, H.M., Pratt, W.B., Gestwicki, J.E., Osawa, Y. and Lieberman, A.P (2010) Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J. Biol. Chem. 285, 15714-15723
68. Congdon, E.E., Wu, J.W., Myeku, N., Figueroa, Y.H., Herman, M., Marinec, P.S., Gestwicki, J.E., Dickey, C.A., Yu, W.H. and Duff, K. (2012) Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8, 609-622
69. Arndt, V., Daniel, C., Nastainczyk, W., Alberti, S. and Hohfeld, J. (2005) BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol. Biol. Cell 16, 5891-5900 (Pubitemid 41752235)
70. Keller, J.N., Hanni, K.B. and Markesbery, W.R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439 (Pubitemid 30418211)
71. Massey, A., Kiffin, R. and Cuervo, A.M. (2004) Pathophysiology of chaperone-mediated autophagy. Int. J. Biochem. Cell Biol. 36, 2420-2434 (Pubitemid 39119756)
72. Ikeda, K., Akiyama, H., Arai, T., Kondo, H., Haga, C., Tsuchiya, K., Yamada, S., Murayama, S. and Hori, A. (2000) Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain? Neurosci. Lett. 284, 187-189 (Pubitemid 30204544)
73. Ikeda, K., Akiyama, H., Arai, T., Kondo, H., Haga, C., Iritani, S. and Tsuchiya, K. (1998) Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Neurosci. Lett. 258, 113-116 (Pubitemid 28566187)
74. Bi, X., Zhou, J. and Lynch, G. (1999) Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease. Exp. Neurol. 158, 312-327 (Pubitemid 29382823)
75. Murakami, N., Oyama, F., Gu, Y., McLennan, I.S., Nonaka, I. and Ihara, Y. (1998) Accumulation of tau in autophagic vacuoles in chloroquine myopathy. J. Neuropathol. Exp. Neurol. 57, 664-673 (Pubitemid 28335055)
76. Oyama, F., Murakami, N. and Ihara, Y. (1998) Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci. Res. 31, 1-8 (Pubitemid 28325592)
77. Hamano, T., Gendron, T.F., Causevic, E., Yen, S.H., Lin, W.L., Isidoro, C., Deture, M. and Ko, L.W. (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur. J. Neurosci. 27, 1119-1130 (Pubitemid 351432336)
78. Berger, Z., Ravikumar, B., Menzies, F.M., Oroz, L.G., Underwood, B.R., Pangalos, M.N., Schmitt, I., Wullner, U., Evert, B.O., O'Kane, C.J. and Rubinsztein, D.C. (2006) Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15, 433-442 (Pubitemid 43159895)
79. Rodriguez-Navarro, J.A., Rodriguez, L., Casarejos, M.J., Solano, R.M., Gomez, A., Perucho, J., Cuervo, A.M., Garcia de Yebenes, J. and Mena, M.A. (2010) Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol. Dis. 39, 423-438
80. Shemesh, O.A. and Spira, M.E. (2010) Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons. Acta Neuropathol. 120, 209-222
81. Lin, W.L., Lewis, J., Yen, S.H., Hutton, M. and Dickson, D.W. (2003) Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. J. Neurocytol. 32, 1091-1105 (Pubitemid 39004719)
82. Lim, F., Hernandez, F., Lucas, J.J., Gomez-Ramos, P., Moran, M.A. and Avila, J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell. Neurosci. 18, 702-714 (Pubitemid 34060150)
83. Pacheco, C.D., Elrick, M.J. and Lieberman, A.P. (2009) Tau normal function influences Niemann-Pick type C disease pathogenesis in mice and modulates autophagy in NPC1-deficient cells. Autophagy 5, 548-550
84. Adams, S.J., Crook, R.J., Deture, M., Randle, S.J., Innes, A.E., Yu, X.Z., Lin, W.L., Dugger, B.N., McBride, M., Hutton, M. et al. (2009) Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. Am. J. Pathol. 175, 1598-1609
85. Li, X., Kumar, Y., Zempel, H., Mandelkow, E.M., Biernat, J. and Mandelkow, E. (2011) Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J. 30, 4825-4837
86. 2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950
87. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H. and Mizushima, N. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889
88. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E. and Tanaka, K. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884
89. Selkoe, D.J. (2011) Alzheimer's disease. Cold Spring Harbor Perspect. Biol. 3, a004457
90. Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J.C., Yarasheski, K.E. and Bateman, R.J. (2010) Decreased clearance of CNS β-amyloid in Alzheimer's disease. Science 330, 1774
91. Yu, W.H., Cuervo, A.M., Kumar, A., Peterhoff, C.M., Schmidt, S.D., Lee, J.H., Mohan, P.S., Mercken, M., Farmery, M.R., Tjernberg, L.O. et al. (2005) Macroautophagy: a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171, 87-98 (Pubitemid 41434604)
92. Tian, Y., Bustos, V., Flajolet, M. and Greengard, P. (2011) A small-molecule enhancer of autophagy decreases levels of Aβ and APP-CTF via Atg5-dependent autophagy pathway. FASEB J. 25, 1934-1942
93. Caccamo, A., Majumder, S., Richardson, A., Strong, R. and Oddo, S. (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120
94. Tseng, B.P., Green, K.N., Chan, J.L., Blurton-Jones, M. and LaFerla, F.M. (2008) Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 29, 1607-1618
95. Cuervo, A.M. (2003) Autophagy and aging: when "all you can eat" is yourself. Sci. Aging Knowledge Environ. 2003, pe25
96. Dasuri, K., Zhang, L., Ebenezer, P., Liu, Y., Fernandez-Kim, S.O. and Keller, J.N. (2009) Aging and dietary restriction alter proteasome biogenesis and composition in the brain and liver. Mech. Ageing Dev. 130, 777-783
97. Vernace, V.A., Schmidt-Glenewinkel, T. and Figueiredo-Pereira, M.E. (2007) Aging and regulated protein degradation: who has the upper hand? Aging Cell 6, 599-606 (Pubitemid 47400042)
98. Vernace, V.A., Arnaud, L., Schmidt-Glenewinkel, T. and Figueiredo-Pereira, M.E. (2007) Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J. 21, 2672-2682 (Pubitemid 47372735)
99. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J. and Rubinsztein, D.C. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595 (Pubitemid 38715985)
100. Lee, B.H., Lee, M.J., Park, S., Oh, D.C., Elsasser, S., Chen, P.C., Gartner, C., Dimova, N., Hanna, J., Gygi, S.P. et al. (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184